ClinicalTrials.Veeva

Menu

Cognitive Impairments in Psychotic Disorders

S

Sheba Medical Center

Status

Enrolling

Conditions

Psychotic Disorders
Cognitive Impairment

Treatments

Diagnostic Test: DAPAR Tests (IQ equivalent test)

Study type

Observational

Funder types

Other

Identifiers

NCT05597579
2974-16-SMC

Details and patient eligibility

About

Patients with Psychotic disorders (Schizophrenia, Bipolar disorder and Schizoaffective disorder) often suffer from significant cognitive impairments, however how these develop and change over time before and after the first psychotic break is unclear. While there are data by several groups, showing that many future patients have significant cognitive impairments years before the onset of psychosis, many future patients seem to be doing well before the manifestation of psychosis, and decline steeply in functioning after their first psychotic episode. Hence the timing of the onset of cognitive impairment in patients with psychotic disorders requires further exploration. The current study will investigate the timing of cognitive impairment by using IQ tests before and after the first psychotic break

Full description

In this study the investigators aim to use the DAPAR tests (A cognitive assessment which all 17 year old Jewish adolescents in Israel undergo to participate in mandatory military service), which measures intelligence, and is equivalent to the IQ test. The subjects will be persons who had their first psychotic break, at least one year following the DAPAR tests. As part of the study, the participants will re-take the DAPAR tests, after the onset of the psychotic illness.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria - Study Group:

  • Patients between the ages 27-18 who had first psychotic break in the last ten years, and more than a year from the date of the DAPAR tests.
  • Diagnoses of schizophrenia, Bipolar disorder or Schizoaffective disorder according to DSM-5 criteria.
  • Previous DAPAR tests at the age of 17.

Inclusion Criteria - Control group:

  • Participants between the ages of 27-18.
  • No history of psychotic break.
  • Previous DAPAR tests at the age of 17.

Exclusion Criteria - Both groups:

  • Participants who did not perform the full battery of the DAPAR tests.
  • Participants who have been appointed a guardian.

Exclusion Criteria - Control group:

  • Participants who have a first-degree relative who suffers from a psychotic disorder.

Trial design

200 participants in 2 patient groups

Study Group
Description:
Patients diagnosed with psychotic disorder.
Treatment:
Diagnostic Test: DAPAR Tests (IQ equivalent test)
Control Group
Description:
Healthy Controls
Treatment:
Diagnostic Test: DAPAR Tests (IQ equivalent test)

Trial contacts and locations

1

Loading...

Central trial contact

Noaz Cohen, MA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems